ResearchMoz

Prefilled Syringes Market (Glass and Plastic) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2013-11-22
No. Of Pages » 74
 Prefilled syringes represent one of the fastest growing segments among the injectable drug delivery devices market. It is mainly due to the various advantages associated with the use of prefilled syringes such as ease of administration, reduced risk of cross contamination, less overfill and ease of handling. 
   
 The two major segments described in the study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period...
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.3.2 Models
1.3.3 Assumptions

Chapter 2 Executive Summary

Chapter 3 Global Prefilled Syringes Market Overview
3.1 Introduction to Prefilled Syringes
3.2 Prefilled Syringes: Manufacturers and Buyers
3.3 Prefilled Syringes: Manufacturing and Packaging Challenges
3.4 Market Dynamics
3.4.1 Market Drivers
3.4.1.1 Continuous growth in injectable drugs market
3.4.1.2 Benefits over traditional vial and syringe packaging systems
3.4.1.3 Rise in demand for point-of-care administration
3.4.1.4 Technological advancements in manufacturing of prefilled syringes
3.4.2 Market Restraints
3.4.2.1 Alternative drug delivery methods
3.4.2.2 Meeting standards set by regulatory authorities
3.4.3 Market Opportunities
3.4.3.1 Cost containment along with use superior material for syringe manufacturing
3.5 Porter’s Five Force Analysis: Global Prefilled Syringes Market
3.5.1 Bargaining power of suppliers
3.5.2 Bargaining power of buyers
3.5.3 Threat of substitutes
3.5.4 Threat of new entrants
3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis: Global Prefilled Syringes Market, by Geography

Chapter 4 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 – 2019
4.1 Overview
4.1.1 Global Prefilled Syringes Market Revenue, by Segment, 2011 – 2019 (USD Million)
4.1.2 Global Prefilled Syringes Market Volume, by Segment, 2011 – 2019 (Million Units)
4.2 Glass prefilled syringes
4.2.1 Global Glass Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
4.2.2 Global Glass Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)
4.3 Plastic prefilled syringes
4.3.1 Global Plastic Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
4.3.2 Global Plastic Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)

Chapter 5 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019
5.1 Overview
5.1.1 Global Prefilled Syringes Market Revenue, by Geography, 2011-2019 (USD Million)
5.1.2 Global Prefilled Syringes Market Volume, by Geography, 2011 - 2019 (Million Units)
5.1.3 Comparative Analysis: Global Prefilled Syringes Market, by Geography, 2012 & 2019 (Value %)
5.2 North America
5.2.1 North America Prefilled Syringes Market Revenue, 2011-2019 (USD Million)
5.2.2 North America Prefilled Syringes Market Volume, 2011-2019 (Million Units)
5.3 Europe
5.3.1 Europe Prefilled Syringes Market Revenue, 2011-2019 (USD Million)
5.3.2 Europe Prefilled Syringes Market Volume, 2011-2019 (Million Units)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Prefilled Syringes Market Revenue, 2011-2019 (USD Million)
5.4.2 Asia-Pacific Prefilled Syringes Market Volume, 2011-2019 (Million Units)
5.5 Rest of the World (Row)
5.5.1 Rest of the World (ROW) Prefilled Syringes Market Revenue, 2011-2019 (USD Million)
5.5.2 Rest of the World (ROW) Prefilled Syringes Market Volume, 2011-2019 (Million Units)

Chapter 6 Competitive Landscape
6.1 Market Share Analysis, by Key Players, 2012 (%)

Chapter 7 Recommendations
7.1 Adopting polymer technology to manufacture prefilled syringes
7.2 Investing in the rapidly growing market of North America, especially the U.S.
7.3 Mergers and acquisitions

Chapter 8 Company Profiles
8.1 Baxter International, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Becton, Dickinson & Company
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Bespak
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.4 Gerresheimer AG
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.5 Nipro Corporation
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.6 Schott AG
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.7 Stevanato Group
8.7.1 Company Overview
8.7.2 Product Portfolio
8.7.3 Business Strategies
8.8 Unilife Corporation
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Recent Developments
8.9 Vetter Pharma International GmbH
8.9.1 Company Overview
8.9.2 Product Portfolio
8.9.3 Business Strategies
8.9.4 Recent Developments
8.10 West Pharmaceutical Services, Inc.
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.11 Ypsomed Holding AG
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments

List of Tables


TABLE 1 Market Snapshot: Global Prefilled Syringes Market (2012 & 2019)
TABLE 2 Global Prefilled Syringe Market Revenue, by Segment, 2011 – 2019 (USD Million)
TABLE 3 Global Prefilled Syringe Market Volume, by Segment, 2011 – 2019 (Million Units)
TABLE 4 Global Prefilled Syringes Market Revenue, by Geography, 2011 – 2019 (USD Million)
TABLE 5 Global Prefilled Syringes Market Volume, by Geography, 2011 – 2019 (Million Units)

List of Figures


FIG. 1 Prefilled Syringes: Market Segmentation
FIG. 2 Global Prefilled Syringes Market:Glass vs Plastic, by Revenue (%) and Volume (%), 2012
FIG. 3 Global Prefilled Syringes Market Revenue, by Geography, 2012 (USD Million)
FIG. 4 Porter’s Five Force Analysis: Global Prefilled Syringes Market
FIG. 5 Market Attractiveness Analysis: Global Prefilled Syringes Market, by Geography (2012)
FIG. 6 Global Glass Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
FIG. 7 Global Glass Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)
FIG. 8 Global Glass Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global Glass Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)
FIG. 10 Comparative Analysis: Global Prefilled Syringes Market, By Geography, 2012 & 2019 (Value %)
FIG. 11 North America Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 North America Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)
FIG. 13 Europe Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Europe Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)
FIG. 15 Asia-Pacific Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Asia-Pacific Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)
FIG. 17 RoW Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 RoW Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)
FIG. 19 Prefilled Syringes: Market Share, by Key Players, 2012 (%)
FIG. 20 Baxter International, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 21 Becton, Dickinson & Company: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 22 Bespak: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 23 Gerresheimer AG: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 24 Nipro Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 25 Schott AG: Annual Revenue, 2011 – 2012 (USD Million)
FIG. 26 Unilife Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 West Pharmaceuticals, Services, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 28 Ypsomed Holding AG: Annual Revenue, 2010 – 2012 (USD Million)

Upcoming Reports:

Greece: sweet potatoes market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the sweet potatoes market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the sweet potatoes market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of...
Greece: maize market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the maize market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the maize market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market...
Benign Prostatic Hyperplasia (BPH) Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Benign prostatic hyperplasia (BPH) or benign prostatic hypertrophy, is a urological disorder that involves proliferation of the cellular components of the prostrate. BPH is the most common form of neoplasm in men. BPH results in the formation of large nodes and nodules in the periurethral region of the prostate. The significantly large nodules compresses the urethral canal that causes to partial or complete urinary tract obstruction which inhibits the normal flow of urine. Obstruction in the urinary tract further leads to complications such as urinary retention, urinary tract infections...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Ford Recalls 65,000 Fusion Models Due to Issues in Ignition Key
Nov 20, 2014  
If anything defines the world of automobiles currently, it would be recalls. It seems that a flood of automobiles has surrounded the global automobiles industry, which once represented a flourishing and highly profitable industry.  The current automobile giants ordering yet another recall is Ford Motors Co. Ford declared on Tuesday that it is recalling nearly 65,000 sedans from...
3D Printed Heart Model for Better Cardiological Treatment
Nov 20, 2014  
According to research carried out by the American Heart Association’s Scientific Sessions 2014, surgeons will be able to treat complex heart disorders in patients, with the help of a three dimensional experimental printed model of the heart. For surgical planning, most cardiac surgeons make use of two dimensional images of the heart taken by MRI, ultrasound, and X-ray. But the problem is...
Los Angeles Auto Show Kicks Off
Nov 20, 2014  
The Los Angeles Auto Show kicked off on Wednesday with a rather upbeat mood. Motoring machines, industry metrics, and hybrid models – the show has lived up to its reputation once more. The Los Angeles Auto Show has begun touring North America from the Los Angeles Convention Center, and the commencement has already had an impact on the market. Gasoline prices dropped under US$3...
Scottish Government to Inject 200 Million Pounds in the Housing Sector
Nov 19, 2014  
The construction and the housing industries of Scotland will get a major financial boost from the Scottish government in terms of additional funding worth 200 million pounds. The main rationale of such a financial boost is to stimulate the housing sector and also safeguarding employment in the construction industry. The housing minister of Scotland has requested the housing leaders to work...
Quarterly Dividend of $0.10 Declared by Tyson Foods, Inc.
Nov 19, 2014  
A quarterly dividend on November 18th was declared by Tyson Foods, reported Analyst Ratings Network.com. The shareholders of the February 27th record will be awarded a dividend of 0.10 per share on March 13th.  This represents a yield of 0.94% and a $0.40 dividend on an annualized basis. However, the ex-dividend date of this particular dividend is February 25th.  Such...